National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LS3	G	Potassium chloride - K+:2.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.60 mmol/l, Sodium acetate - Cl-:112 mmol/l, Sodium chloride - Na+:140 mmol/l		Injectable solution	L.L
C09DB07	CANDAM	G	Candesartan cilexetil - 16mg, Amlodipine - 5mg		Capsule, hard	1,376,095 L.L
N07X	CEREBROLYSIN	G	Cerebrolysin - 215.2mg/ml	215.2mg/ml	Injectable concentrated solution	2,303,346 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS R	G	Potassium chloride - K+:1.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.40 mmol/l, Sodium acetate - Cl-:105.8 mmol/l, Sodium chloride - Na+:140.5 mmol/l		Injectable solution	L.L
C09DB07	CORONOPINE	G	Candesartan cilexetil - 16mg, Amlodipine - 5mg		Capsule, hard	1,638,144 L.L
N07X	CEREBROLYSIN	G	Cerebrolysin - 215.2mg/ml	215.2mg/ml	Injectable concentrated solution	3,886,393 L.L
B05ZA	CONCENTRATE SOLUTIONFOR HEMODIALYSIS TYPE A	G	Hemodialytics, concentrates -		Injectable solution	L.L
C09DB07	CANDAM	G	Candesartan cilexetil - 16mg, Amlodipine - 10mg		Capsule, hard	1,376,095 L.L
L01CD04	CABAZITAXEL EVER PHARMA	G	Cabazitaxel - 60mg/6ml	10mg/ml	Injectable concentrate for solution	54,531,485 L.L
A03FA08	CINITREX	G	Cinitapride - 1mg	1mg	Tablet	636,981 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE B+	G	Hemodialytics, concentrates -		Injectable solution	L.L
C09DB07	CORONOPINE	G	Candesartan cilexetil - 16mg, Amlodipine - 10mg		Capsule, hard	1,540,044 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE J	G	Hemodialytics, concentrates -		Injectable solution	L.L
C09DB07	CORONOPINE	G	Candesartan cilexetil - 8mg, Amlodipine - 10mg		Capsule, hard	1,368,032 L.L
L01XX05	CUREAML	G	Hydroxycarbamide (or Hydroxyurea) - 500mg	500mg	Capsule	1,228,272 L.L
L01XX05	CYTODROX	G	Hydroxycarbamide (or Hydroxyurea) - 500mg	500mg	Capsule	3,301,821 L.L
B01AC04	CERUVIN	G	Clopidogrel (Bisulfate) - 75mg	75mg	Tablet	240,548 L.L
G03DA04	CYCLOGEST	G	Progesterone - 400mg	400mg	Pessary	1,546,763 L.L
B01AC04	CLODOR	G	Clopidogrel (Bisulfate) - 75mg	75mg	Tablet	1,148,025 L.L
B01AC04	CLOPI TAD	G	Clopidogrel (Bisulfate) - 75mg	75mg	Tablet, film coated	911,125 L.L
B01AC04	CLOPIDOGREL ARROW	G	Clopidogrel besylate - 75mg	75mg	Tablet, film coated	658,483 L.L
B01AC04	CLOPIKEY	G	Clopidogrel (Bisulfate) - 75mg	75mg	Tablet	748,520 L.L
B01AC04	CLOTRIX 75	G	Clopidogrel (hydrogenosulfate) - 75mg	75mg	Tablet, film coated	1,109,630 L.L
B01AC04	CLOTRIX 75	G	Clopidogrel (hydrogenosulfate) - 75mg	75mg	Tablet, film coated	1,035,399 L.L
J01DH51	CELLABAXIN	G	Imipenem (monohydrate) - 500mg, Cilastatin (sodium) - 500mg		Injectable solution	10,699,559 L.L
J01DH51	CILANEM	G	Imipenem anhydrous - 500mg, Cilastatin (sodium) - 500mg		Injectable solution	850,652 L.L
R05X	COFEX	G	Paracetamol - 33.3mg/5ml, Guaifenesin - 33.3mg/5ml, Oxomemazine HCl - 1.65mg/5ml		Syrup	154,542 L.L
L01EA01	CEMIVIL	G	Imatinib - 400mg	400mg	Tablet, film coated	41,106,321 L.L
M01AB05	CLOREN ADULTS	G	Diclofenac sodium - 100mg	100mg	Suppository	598,970 L.L
R05X	COLDIN	G	Caffeine - 30mg, Noscapine - 10mg, Pseudoephedrine HCl - 30mg, Pyrilamine maleate (Mepyramine) - 15mg, Paracetamol - 300mg		Capsule	386,515 L.L

National Cancer Registry (NCR)